跳至主要内容
临床试验/CTRI/2024/05/067526
CTRI/2024/05/067526已完成2/3 期

A single arm clinical study to evaluate the efficacy of chaturjataka vati in the management of hyperlipidemia

Dr. Amey Rajendra Ekhande1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2024年5月27日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
35
试验地点
1
主要终点
To reduce LDL, Total cholesterol, Triglycerides and Increase HDL levels

研究概览

简要总结

To study the efficacy of Chaturjataka vati in the management of hyperlipidaemia. Total 35 patients will be enrolled. Two tablets of 500 mg will be administered twice a day before food along with the lukewarm water for duration of 60 days and follow up will be done on 20th 40th 60th day and final conclusion will be drawn on the basis of statistical methods.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Age limit from 30 to 70 yrs.
  • Newly detected Hyperlipidemic or known case of Hyperlipidemic patients.

排除标准

  • Pregnant women & lactating mothers.
  • Patient with severe renal, hepatic, coronary heart diseases.

结局指标

主要结局

To reduce LDL, Total cholesterol, Triglycerides and Increase HDL levels

时间窗: 60 days study. 20th, 40th, 60th follow up days

次要结局

  • 1) To study present day food habits and lifestyle as a causative factor for Hyperlipidemia.(2) To study the concept and role of Agnideepana and Amapachana in the management of)

研究者

发起方
Dr. Amey Rajendra Ekhande
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Amey Rajendra Ekhande

Dr. D. Y. Patil college of Ayurveda and Research center

研究点 (1)

Loading locations...

相似试验